Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.6
2.6
Journals
Medicina
Special Issues
Percutaneous Interventions in Ischemic Heart Disease in the Course of...
share announcement

Percutaneous Interventions in Ischemic Heart Disease in the Course of Coronary Atherosclerosis — Current State of Knowledge, New Methods and Devices

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 1046

Special Issue Editor

Dr. Rafał Januszek

E-Mail Website
Guest Editor
Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Cracow University, Kraków, Poland
Interests: cardiology; interventional cardiology; acute myocardial infarctions, rotablation, coronary artery calcifications; optical coherence tomography; respiratory medicine; clinical rehabilitation; internal medicine; also experience in nephrology; angiology; peripheral artery disease

Special Issue Information

Dear Colleagues,

This Special Issue centers on covering the latest trends and achievements in interventional cardiology, both in the treatment of acute coronary syndrome and patients with chronic coronary syndromes. Publications in the area of treatment novelties relating the field of new imaging devices and those used during interventions and pharmacological treatment are particularly welcome. This also applies to the rapidly expanding treatment offer for patients with a reduced left ventricular ejection fraction and multivessel disease who are not qualified for cardiac surgery, mainly refers to the rapidly growing portfolio of devices for plaque ablation and modification, as well as stentless techniques, including drug-eluting balloons.

Dr. Rafał Januszek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery atherosclerosis
  • percutaneous coronary interventions
  • new devices portfolio for percutaneous revascularisation
  • advanced calcifications
  • multivessel disease
  • decreased left ventricle ejection fraction
  • left ventricle support devices
  • plaque ablation devices
  • drug-coated balloons
  • new devices and treatment for acute myocardial infarction

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

11 pages, 678 KiB  
Article
Implementation of Microcirculation Examination in Clinical Practice—Insights from the Nationwide POL-MKW Registry
by Rafał Januszek, Łukasz Kołtowski, Mariusz Tomaniak, Wojciech Wańha, Wojciech Wojakowski, Marek Grygier, Wojciech Siłka, Grzegorz Jan Horszczaruk, Bartosz Czarniak, Radosław Kręcki, Bartłomiej Guzik, Jacek Legutko, Tomasz Pawłowski, Paweł Wnęk, Marek Roik, Sylwia Sławek-Szmyt, Miłosz Jaguszewski, Tomasz Roleder, Miłosz Dziarmaga and Stanisław Bartuś
Medicina 2024, 60(2), 277; https://0-doi-org.brum.beds.ac.uk/10.3390/medicina60020277 - 05 Feb 2024
Viewed by 807
Abstract
Background and Objectives: The assessment of coronary microcirculation may facilitate risk stratification and treatment adjustment. The aim of this study was to evaluate patients’ clinical presentation and treatment following coronary microcirculation assessment, as well as factors associated with an abnormal coronary flow reserve [...] Read more.
Background and Objectives: The assessment of coronary microcirculation may facilitate risk stratification and treatment adjustment. The aim of this study was to evaluate patients’ clinical presentation and treatment following coronary microcirculation assessment, as well as factors associated with an abnormal coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) values. Materials and Results: This retrospective analysis included 223 patients gathered from the national registry of invasive coronary microvascular testing collected between 2018 and 2023. Results: The frequency of coronary microcirculatory assessments in Poland has steadily increased since 2018. Patients with impaired IMR (≥25) were less burdened with comorbidities. Patients with normal IMR underwent revascularisation attempts more frequently (11.9% vs. 29.8%, p = 0.003). After microcirculation testing, calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors were added more often for patients with IMR and CFR abnormalities, respectively, as compared to control groups. Moreover, patients with coronary microvascular dysfunction (CMD, defined as CFR and/or IMR abnormality), regardless of treatment choice following microcirculation assessment, were provided with trimetazidine (23.2%) and dihydropyridine CCBs (26.4%) more frequently than those without CMD who were treated conservatively (6.8%) and by revascularisation (4.2% with p = 0.002 and 0% with p < 0.001, respectively). Multivariable analysis revealed no association between angina symptoms and IMR or CFR impairment. Conclusions: The frequency of coronary microcirculatory assessments in Poland has steadily increased. Angina symptoms were not associated with either IMR or CFR impairment. After microcirculation assessment, patients with impaired microcirculation, expressed as either low CFR, high IMR or both, received additional pharmacotherapy treatment more often. Full article
(This article belongs to the Special Issue Percutaneous Interventions in Ischemic Heart Disease in the Course of Coronary Atherosclerosis — Current State of Knowledge, New Methods and Devices)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop